Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Intravenous (IV) Iron Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Intravenous (IV) Iron Drugsmarket, defines the market attractiveness level of Intravenous (IV) Iron Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Intravenous (IV) Iron Drugs industry, describes the types of Intravenous (IV) Iron Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intravenous (IV) Iron Drugs market and the development prospects and opportunities of Intravenous (IV) Iron Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intravenous (IV) Iron Drugs market in Chapter 13.
By Player:
Dalichi Sankyo
AMAG Pharmaceuticals
Takeda Pharmaceutical
Luitpold Pharmaceuticals
Pharmacosmos
Allergan
Sanofi
By Type:
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
By End-User:
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Intravenous (IV) Iron Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Intravenous (IV) Iron Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Intravenous (IV) Iron Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Intravenous (IV) Iron Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Intravenous (IV) Iron Drugs Market Analysis and Outlook to 2022
-
7.1 Global Intravenous (IV) Iron Drugs Consumption (2017-2022)
-
7.2 United States Intravenous (IV) Iron Drugs Consumption (2017-2022)
-
7.3 Europe Intravenous (IV) Iron Drugs Consumption (2017-2022)
-
7.4 China Intravenous (IV) Iron Drugs Consumption (2017-2022)
-
7.5 Japan Intravenous (IV) Iron Drugs Consumption (2017-2022)
-
7.6 India Intravenous (IV) Iron Drugs Consumption (2017-2022)
-
7.7 South Korea Intravenous (IV) Iron Drugs Consumption (2017-2022)
8 Region and Country-wise Intravenous (IV) Iron Drugs Market Analysis and Outlook to 2028
-
8.1 Global Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.2 United States Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.4 China Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.6 India Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Intravenous (IV) Iron Drugs Consumption Forecast (2022-2028)
9 Global Intravenous (IV) Iron Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Intravenous (IV) Iron Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ferric Carboxymaltose Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Iron Sucrose Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Iron Dextran Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Intravenous (IV) Iron Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Nephrology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Gynecology & Obstetrics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastroenterology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Intravenous (IV) Iron Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ferric Carboxymaltose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Iron Sucrose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Iron Dextran Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Nephrology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Gynecology & Obstetrics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gastroenterology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Intravenous (IV) Iron Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Intravenous (IV) Iron Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Intravenous (IV) Iron Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Intravenous (IV) Iron Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Intravenous (IV) Iron Drugs Market Competitive Analysis
-
14.1 Dalichi Sankyo
-
14.1.1 Dalichi Sankyo Company Details
-
14.1.2 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Product and Service
-
14.2 AMAG Pharmaceuticals
-
14.2.1 AMAG Pharmaceuticals Company Details
-
14.2.2 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product and Service
-
14.3 Takeda Pharmaceutical
-
14.3.1 Takeda Pharmaceutical Company Details
-
14.3.2 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product and Service
-
14.4 Luitpold Pharmaceuticals
-
14.4.1 Luitpold Pharmaceuticals Company Details
-
14.4.2 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product and Service
-
14.5 Pharmacosmos
-
14.5.1 Pharmacosmos Company Details
-
14.5.2 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pharmacosmos Intravenous (IV) Iron Drugs Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Intravenous (IV) Iron Drugs Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Intravenous (IV) Iron Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Intravenous (IV) Iron Drugs
-
Figure Intravenous (IV) Iron Drugs Picture
-
Table Global Intravenous (IV) Iron Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intravenous (IV) Iron Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intravenous (IV) Iron Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Intravenous (IV) Iron Drugs Consumption by Country (2017-2022)
-
Figure United States Intravenous (IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Intravenous (IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Intravenous (IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Intravenous (IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Intravenous (IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Intravenous (IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous (IV) Iron Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Intravenous (IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ferric Carboxymaltose Consumption and Growth Rate (2017-2022)
-
Figure Global Iron Sucrose Consumption and Growth Rate (2017-2022)
-
Figure Global Iron Dextran Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Nephrology Consumption and Growth Rate (2017-2022)
-
Figure Global Gynecology & Obstetrics Consumption and Growth Rate (2017-2022)
-
Figure Global Gastroenterology Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ferric Carboxymaltose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iron Sucrose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iron Dextran Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nephrology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gynecology & Obstetrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastroenterology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Intravenous (IV) Iron Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Intravenous (IV) Iron Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Dalichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dalichi Sankyo Intravenous (IV) Iron Drugs Product and Service
-
Table AMAG Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product and Service
-
Table Luitpold Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product and Service
-
Table Pharmacosmos (Foundation Year, Company Profile and etc.)
-
Table Pharmacosmos Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmacosmos Intravenous (IV) Iron Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Intravenous (IV) Iron Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Intravenous (IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Intravenous (IV) Iron Drugs Product and Service
-
